The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
FibroGen Inc (NASDAQ: FGEN) closed the day trading at $0.29 down -9.59% from the previous closing price of $0.32. In other words, the price has decreased by -$9.59 from its previous closing price. On the day, 1.33 million shares were traded.
Ratios:
For a better understanding of FGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 24 ’25 when Wettig Thane bought 145,000 shares for $0.35 per share. The transaction valued at 50,663 led to the insider holds 543,329 shares of the business.
Schoeneck James A bought 250,000 shares of FGEN for $88,000 on Mar 20 ’25. The Director now owns 323,722 shares after completing the transaction at $0.35 per share. On Mar 21 ’25, another insider, Schoeneck James A, who serves as the Director of the company, bought 50,000 shares for $0.34 each. As a result, the insider paid 17,040 and bolstered with 373,722 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28.
Stock Price History:
Over the past 52 weeks, FGEN has reached a high of $1.53, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is -7.10%, while the 200-Day Moving Average is calculated to be -27.04%.
Shares Statistics:
A total of 101.04M shares are outstanding, with a floating share count of 94.08M. Insiders hold about 6.90% of the company’s shares, while institutions hold 32.67% stake in the company.
